Date | Insider | Price | Amount |
---|---|---|---|
3-31-2017 Insider Buy |
Ventures VI LP Rho >10% Owner |
$18.19 CAGR » |
$9,095,700.00 500,000 shares |
3-17-2016 Insider Buy |
Ventures VI LP Rho >10% Owner |
$4.87 CAGR » |
$1,949,202.91 400,000 shares |
8-18-2015 Insider Buy |
Josef Schoell Chief Financial Officer |
$22.10 CAGR » |
$66,300.00 3,000 shares |
8-4-2015 Insider Buy |
Joseph William Stauffer Chief Medical Officer |
$18.60 CAGR » |
$37,200.00 2,000 shares |
2-5-2014 Insider Buy |
Ventures VI LP Rho >10% Owner |
$11.00 CAGR » |
$2,483,998.00 225,818 shares |
2-5-2014 Insider Buy |
Martin Vogelbaum Director |
$11.00 CAGR » |
$2,483,998.00 225,818 shares |
2-5-2014 Insider Buy |
Biopharma Partners LP Alta III >10% Owner |
$11.00 CAGR » |
$1,240,987.00 112,817 shares |
Also See: Institutional Holders of CARA
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/03/2017 | |
End date: | 04/25/2024 | |
Start price/share: | $17.92 | |
End price/share: | $0.70 | |
Dividends collected/share: | $0.00 | |
Total return: | -96.09% | |
Average Annual Total Return: | -36.80% | |
Starting investment: | $10,000.00 | |
Ending investment: | $390.77 | |
Years: | 7.07 |
CARA Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent CARA insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding CARA
Free CARA Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |